Revenue calculator

Peptide Therapy

Peptide programs (BPC-157, CJC/Ipamorelin, PT-141, etc.) typically sold as monthly programs. Regulatory environment is shifting — many peptides were placed on Category 2 lists by FDA in 2024–2025. Verify legal status of each peptide in your jurisdiction.

Default projection5 new patients/month · national pricing · mid band · retail procurement

Year-1 revenue

$70,241

Ramp: 51%

Year-3 revenue

$228,512

Mature steady state

Year-1 gross profit

$48,165

Margin: 68.6%

Per-procedure price

$350

Mid band, national average

This is a starting scenario. Adjust volume, region, band, and procurement tier in the interactive builder.

Pricing

National-average price per per month. Regional adjustments apply: tier-1 metros are typically 20-50% above national.

Low

$200

Mid

$350

High

$600

  • Modern AestheticsModern Aesthetics magazine published surveys link

Time, repeat cadence & retention

Returning appt

15 min

+ 5 min prep

New-patient appt

same

Repeat cadence

1 mo

Range 1-1 mo

Year-1 retention

50%

Y2 30% · Y3 18%

  • American Med Spa Association (AmSpa)AmSpa State of the Medical Spa Industry Report 2024 link

Procurement & cost of goods

Compounded pharmacy cost per month.

COGS low

$60

COGS mid

$110

COGS high

$200

  • Modern AestheticsModern Aesthetics magazine published surveys link

Provider scope

Who can perform this procedure (varies by state):

  • NP
  • PA
  • MD
  • DO

Patient-acquisition cost

Cost per acquired patient by channel (per-procedure-acquired-patient basis):

  • Paid ads$80 $200
  • Organic$20 $60
  • Referral$0 $40

Volume ramp curve

Fraction of mature monthly volume achievable at each month from launch.

Month 1

10%

Month 2

20%

Month 3

30%

Month 6

55%

Month 12

80%

Month 24

100%

  • American Med Spa Association (AmSpa)AmSpa State of the Medical Spa Industry Report 2025 link

Build a full P&L projection

Mix procedures, set regional pricing, model volume ramps, and project a full practice P&L.